Patent · US Active

3H,4H-thieno[2,3-d]pyrimidin-4-one derivatives as TRPA1 inhibitors

US12180223B2 · kind B2 · utility

0Cited by

6References

9Claims

0Family size

Assignee

Boehringer Ingelheim International GmbH · DE

Inventors

Florian Paul Christian Binder · Maselheim, DE
Jens WILLWACHER · Biberach an der Riß, DE
Martin Fleck · Warthausen, DE

Key dates

Filing date	Apr 13, 2022
Grant date	Dec 31, 2024
Priority date	—
Expiry date	Oct 29, 2042

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P29/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present disclosure provides certain 3H,4H-thieno[2,3-d]pyrimidin-4-one derivatives that are inhibitors of transient receptor potential ankyrin 1 (TRPA1), and are therefore useful for the treatment of diseases treatable by inhibition of TRPA1. Also provided are pharmaceutical compositions containing the same, and processes for preparing said compounds.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.